Additionally, PKMYT1 and WEE1 inhibition synthetically eradicates cancers with high levels of RS such as glioma [205] and HGSOC, relatively sparing normal tissues or cancers with lower levels of RS [206]. This evidence concerns the gene WEE1 and cancer.